Abiomed INC ABIOMED ORD SHS/ US0036541003 /
| 2022-12-21 6:56:16 PM | Chg. - | Volume | Bid6:00:09 AM | Ask6:00:09 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 380.7907USD | - | 110 Turnover: 3,807.3628 |
-Bid Size: - | -Ask Size: - | 17.18 bill.USD | - | 127.01 |
Assets
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 6.3000 | 6.4000 | 6.5000 | 6.8890 | 9.1270 | ||||||
| Intangible Assets | 1.6000 | 0.0000 | 0.0000 | - | - | ||||||
| Long-Term Investments | - | - | - | 41.7610 | 13.9960 | ||||||
| Fixed Assets | - | - | - | 87.4410 | 118.2280 | ||||||
| Inventories | 7.5000 | 11.1000 | 14.9000 | 13.9480 | 16.7740 | ||||||
| Accounts Receivable | 15.4000 | 20.5000 | 22.9000 | 24.3570 | 31.8280 | ||||||
| Cash and Cash Equivalents | 5.8000 | 6 | 9.5000 | 20.9160 | 22.4010 | ||||||
| Current Assets | 84.7000 | 110.5000 | 116.6000 | 117.9660 | 220.1390 | ||||||
| Total Assets | 131.6000 | 153.9000 | 170 | 205.4070 | 338.3670 | ||||||
Liabilities
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.3000 | 6.9000 | 7.7000 | 7.7460 | 10.3890 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 4 | 4.8000 | 5.6000 | 6.4000 | .8000 | ||||||
| Liabilities | 26.8000 | 27.6000 | 32.9000 | 37.0540 | 46.8070 | ||||||
| Share Capital | - | - | - | .4110 | .4130 | ||||||
| Total Equity | 104.7000 | 126.3000 | 137.1000 | 168.3530 | 291.5600 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 131.6000 | 153.9000 | 170 | 205.4070 | 338.3670 | ||||||
Income Statement
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 101.2000 | 126.4000 | 158.1000 | 183.6430 | 230.3110 | ||||||
| Depreciation (total) | 1.4000 | 1.5000 | .1000 | 2.5080 | 2.7700 | ||||||
| Operating Result | -11.2000 | 1.5000 | 16.5000 | 8.3630 | 28.6660 | ||||||
| Interest Income | - | - | - | .1180 | .1960 | ||||||
| Income Before Taxes | -10.9000 | 2.5000 | 16.9000 | 8.5300 | 28.7650 | ||||||
| Income Taxes | .9000 | 1 | 1.8000 | 1.1790 | -84.9230 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -11.8000 | 1.5000 | 15 | 7.3510 | 113.6880 | ||||||
Per Share
Cash Flow
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1.6000 | 3.6000 | 26.4000 | 23.4660 | 43.2900 | ||||||
| Cash Flow from Investing Activities | -2.4000 | -17.5000 | -10.3000 | -22.2720 | -49.8630 | ||||||
| Cash Flow from Financing | 1.4000 | 14.7000 | -11.8000 | 9.6320 | 9.5230 | ||||||
| Decrease / Increase in Cash | 1 | .2000 | 3.5000 | 11.4650 | 1.4850 | ||||||
| Employees | 374 | 397 | 467 | 511 | 589 | ||||||
